Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v1-EN
Language French English
Date Updated 2018-09-08 2018-09-08
Drug Identification Number 00733067 00733067
Brand name APO-RANITIDINE TABLET 300MG APO-RANITIDINE TABLET 300MG
Common or Proper name RANITIDINE RANITIDINE
Company Name APOTEX INC APOTEX INC
Ingredients RANITIDINE RANITIDINE
Strength(s) 300MG 300MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 500 BTL 500 BTL
ATC code A02BA A02BA
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2019-08-28 2019-08-28
Actual discontinuation date
Remaining supply date 2019-08-28 2019-08-28
Discontinuation status To be discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments